Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

India · Delayed Price · Currency is INR

520.70

+6.10 (1.19%)

Nov 9, 2026, 11:46 AM IST

Market Cap	165.08B +3.6%
Revenue (ttm)	23.58B +25.6%
Net Income	1.70B +48.1%
EPS	5.31 +46.4%
Shares Out	317.03M
PE Ratio	98.13
Forward PE	68.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,190
Open	519.70
Previous Close	514.60
Day's Range	509.20 - 523.50
52-Week Range	401.00 - 567.75
Beta	n/a
Analysts	Strong Buy
Price Target	606.17 (+16.41%)
Earnings Date	Nov 5, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addit... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol AGARWALEYE

Full Company Profile

Financial Performance

In fiscal year 2026, Dr. Agarwal's Health Care's revenue was 20.80 billion, an increase of 21.57% compared to the previous year's 17.11 billion. Earnings were 1.33 billion, an increase of 59.59%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for AGARWALEYE stock is "Strong Buy." The 12-month stock price target is ₹606.17, which is an increase of 16.41% from the latest price.

Price Target

₹606.17

(16.41% upside)

Analyst Consensus: Strong Buy

Stock Forecasts